24 Fibromyalgia Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Fibromyalgia Studies in New York

NCT01885767Recruiting

Neurofibromatosis (NF) Registry Portal

The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted...

New York, NY20,000 participantsThe Children's Tumor Foundation

View Study Details

NCT01967511Recruiting

Defining the Basis of Fibromuscular Dysplasia (FMD)

The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia...

New York, NY600 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06951217Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants ...

New York, NYPHASE2340 participantsAvalyn Pharma Inc.

View Study Details

NCT07226648Recruiting

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four tre...

New York, NYNA180 participantsSPIRE Therapeutics Inc.

View Study Details

NCT06449677Recruiting

Bionic Pancreas in CFRD

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using...

New York, NYPHASE3150 participantsJaeb Center for Health Research

View Study Details

NCT05571059Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....

New York, NYPHASE2128 participantsCumberland Pharmaceuticals

View Study Details

NCT04374305Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as ne...

New York, NYPHASE2109 participantsScott R. Plotkin, MD, PhD

View Study Details

NCT04281381Recruiting

Observing People With Desmoid-Type Fibromatosis

The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months....

New York, NY100 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

New York, NYPHASE380 participantsBoehringer Ingelheim

View Study Details

NCT06343805Recruiting

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

AJX-101 is a first-in-human (FIH), phase 1, non-randomized, multi-center, open-label clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), clinical activity and chang...

New York, NYPHASE176 participantsAjax Therapeutics, Inc.

View Study Details

NCT07036523Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

This study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can participate in the study if they have a forced vital capacity (FVC) greater than or ...

New York, NYPHASE271 participantsBoehringer Ingelheim

View Study Details

NCT06517875Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

The purpose of this Phase 2 study is to evaluate the efficacy and safety of momelotinib (MMB) in combination with luspatercept (LUSPA) in participants with transfusion dependence (TD) primary myelofib...

New York, NYPHASE268 participantsGlaxoSmithKline

View Study Details

NCT05980806Recruiting

A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

The main purpose of this study with corresponding optional expansion is to evaluate the efficacy of selinexor in JAKi-naïve participants with myelofibrosis (MF) and moderate thrombocytopenia based on ...

New York, NYPHASE258 participantsKaryopharm Therapeutics Inc

View Study Details

NCT07423377Recruiting

Vestibular Innovation in Pain 2

Fibromyalgia is the most common centralized pain disorder, affecting up to 3% of the population. Current treatments are incompletely effective, often poorly tolerated, and costly: there remains an urg...

New York, NYNA56 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06773195Recruiting

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test diffe...

New York, NYPHASE137 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05219695Recruiting

Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)

The objective of this study is to demonstrate the initial clinical feasibility of using Harmonic Motion Imaging (HMI) for Focused Ultrasound Surgery (FUS) guidance and monitoring in patients with beni...

New York, NYNA36 participantsColumbia University

View Study Details

NCT05371964Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis

The purpose of the study is to identify the recommended Part 2 dose (R2PD) of imetelstat sodium in combination with ruxolitinib in participants with myelofibrosis (MF) in Part 1, and to evaluate the s...

New York, NYPHASE136 participantsGeron Corporation

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

New York, NYPHASE225 participantsHealx Limited

View Study Details

NCT05423691Recruiting

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

To assess the safety and tolerability of CK0804 as add-on therapy in participants with myelofibrosis, with suboptimal response to ruxolitinib...

New York, NYPHASE124 participantsCellenkos, Inc.

View Study Details

NCT05504837Recruiting

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis....

New York, NYPHASE120 participantsKrystal Biotech, Inc.

View Study Details

NCT05714072Recruiting

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

The study is being done to see if the combination of ruxolitinib and abemaciclib is a safe and effective treatment for people with primary or post-polycythemia vera/essential thrombocythemia myelofibr...

New York, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06526923Recruiting

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy....

New York, NYPHASE115 participantsSpirovant Sciences, Inc.

View Study Details

NCT05835466Recruiting

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

This is an open label, phase II study to assess the efficacy, safety, and tolerability of Reparixin in patients with DIPSS intermediate-2, or high-risk primary myelofibrosis (PMF), post essential thro...

New York, NYPHASE210 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT05025488Recruiting

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

The primary objective of this study is to assess the safety and tolerability of administrating mutated-CALR peptide Vaccine to patients with MPN. The researchers plan to enroll 10 patients over a 12 m...

New York, NYPHASE110 participantsMarina Kremyanskaya

View Study Details

About Fibromyalgia Clinical Trials in New York

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 24 fibromyalgia clinical trials recruiting participants in New York, NY. These studies are seeking a combined 22,247 participants. Research is being sponsored by The Children's Tumor Foundation, Icahn School of Medicine at Mount Sinai, Avalyn Pharma Inc. and 16 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in New York — FAQ

Are there fibromyalgia clinical trials in New York?

Yes, there are 24 fibromyalgia clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 24 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated July 17, 2026 from ClinicalTrials.gov